Ruxolitinib: the first agent approved for myelofibrosis.
作者信息
Verstovsek Srdan
机构信息
Department of Leukemia, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
出版信息
Clin Adv Hematol Oncol. 2012 Feb;10(2):111-3.
PMID:22402352
Abstract
摘要
Zotero 插件